I think the big remaining question for me (as someone who got a booster a while ago) is whether it’s worth it to wait for the next RaDVaC vaccine. They claim that the current version should work against Omicron, but that they plan to release an updated version ‘soon’ anyway:
Current RaDVaC peptide vaccine designs are largely resistant to the mutations of Omicron. This is in keeping with the strategy of RaDVaC vaccines to be more robust against variants.
[...]
Recent discoveries about SARS-CoV-2, in addition to Omicron, have suggested minor refinements to RaDVaC Gen 11. Therefore, RaDVaC will soon release the Gen 12 vaccine design.
(I could make the current version and then make another batch with whatever the new peptides are, but it’s fairly expensive to get ingredients for).
Also, related to the expense, I wonder if we could setup some sort of buying group since I think the ingredients are mostly expensive because the minimum quantities are enough for hundreds of doses. Not sure if there’s any legal complexity there though.
I think the big remaining question for me (as someone who got a booster a while ago) is whether it’s worth it to wait for the next RaDVaC vaccine. They claim that the current version should work against Omicron, but that they plan to release an updated version ‘soon’ anyway:
(I could make the current version and then make another batch with whatever the new peptides are, but it’s fairly expensive to get ingredients for).
Also, related to the expense, I wonder if we could setup some sort of buying group since I think the ingredients are mostly expensive because the minimum quantities are enough for hundreds of doses. Not sure if there’s any legal complexity there though.